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Abstract. To identify potential risk factors among the
therapeutic regimen and life style which may increase
the risk for stroke, a pair matched case-control study
was conducted in Gaza Strip among 112 patients,
who had been hospitalized for acute stroke and his-
tory of hypertension, and 224 controls with history of
hypertension. Conditional logistic regression models
show signiﬁcant associations between stroke and
medication not taking as prescribed (OR ¼ 6.07;
95% CI: 1.53, 24.07), using excessive salt at meals
(OR ¼ 4.51; 95% CI: 2.05, 9.90), eating diet high in
fat (OR ¼ 4.67; 95% CI: 2.09, 10.40), and high level
of stress (OR ¼ 2.77; 95% CI: 1.43, 5.38). No sig-
niﬁcant association between smoking and the devel-
opment of stroke (OR ¼ 2.12; 95% CI: 0.82, 5.51)
was found. Regular physical exercise was a protective
factor (OR ¼ 0.26; 95% CI: 0.12, 0.57). Using
excessive salt at meals was a signiﬁcant risk factor
(OR ¼ 16.61; 95% CI: 4.40, 62.80) in people having
low level of stress, whereas it was not signiﬁcant in
people having high level of stress. (OR ¼ 1.76; 95%
CI: 0.58, 5.33). Smoking in combination with low
level of stress was a signiﬁcant risk factor for stroke
(OR ¼ 9.88; 95% CI: 2.52, 38.78), but a non-signiﬁ-
cant protective factor in combination with high level
of stress (OR ¼ 0.52; 95% CI: 0.14, 1.99). An
increase in compliance with the pharmacological and
non-pharmacological therapeutic regimen might be a
key to a reduction of stroke incidence and prevalence
among hypertensive patients.
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Background
Hypertension is worldwide a public health problem
aﬀecting about 20% of the adult population,
responsible for over 70% of stroke in women and
40% in men and the single most important potent risk
factor for stroke [1–7]. It is one of the main causes
which contribute to disability, health care costs, and
stroke mortality [8, 9]. Stroke, a possible consequence
of hypertension often leads to death and disability [4,
10–12]. The American Heart Association estimates
that stroke occurs in 500,000 Americans each year
[13–15]. In developing countries, stroke remains as
one of the major public health problems [12].
In Gaza Strip and West Bank cerebrovascular
diseases are the second leading cause of death of the
total cardiovascular disease mortality (35% in Gaza
Strip, and 27.5% in West Bank). The mortality rate
among people of 60 years of age and over is highest
in patients with cerebrovascular disease (15.2%), in
comparison to hypertension (11.3%), malignant
neoplasm (9.1%), diabetes mellitus (5.3%), and renal
failure (3.2%) [16].
Non-compliance to the pharmaceutical and
non-pharmaceutical therapeutic regimen (usage of
anti-hypertensive medication, dietary restrictions of
sodium and fat, weight reduction, exercise program)
is associated with complications of hypertension,
such as stroke [15, 17–19]. Surveys indicate that
therapeutic compliance to non-pharmacological ad-
vice and even to drug prescriptions is far from being
excellent. Non-compliance limits the eﬃcacy of the
prevention strategies and contributes to a markedly
increase of associated cardiovascular complications
[20]. Further potential risk factors for stroke are
obesity, high cholesterol, smoking, and alcohol con-
sumption [21]. In addition to hypertension these risk
factors may increase the risk of stroke [17–19, 22].
Physical activity is a signiﬁcant protective factor in
men, but not in women [23].
A WHO expert committee [1] reported that the
prevention of stroke by anti-hypertensive therapy has
been successful, but more research is required to
evaluate the eﬀectiveness of anti-hypertensive therapy
and life style modiﬁcation in preventing stroke and
recurrent stroke, especially the impact of anti-
hypertensive treatment in secondary prevention of
stroke [1, 6].
A case-control study was carried out in Gaza Strip
to investigate whether a signiﬁcant association exists
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between non-compliance with the therapeutic regi-
men (e.g. usage of anti-hypertensive medication,
dietary restrictions in sodium and fat, implementa-
tion of weight reduction and exercise program, reg-
ular follow-up health care, and smoking) and the
development of stroke among hypertensive patients.
Materials and methods
Cases and controls were recruited from the same
geographical area in Gaza Strip [24, 25]. Three main
hospitals in Gaza Strip (Shefa, Nasser, and European
hospital) and the geographically and administratively
related primary health care clinics were pinpointed
for the selection of the study population. Each se-
lected primary health care clinic was associated with
one of the three hospitals in relation to diagnostic
and treatment as well as follow-up procedures. The
population under study consists of patients aged be-
tween 35 and 69 years.
Selection of cases and controls
All available discharge data of patients from the
selected hospitals were screened for cases. Patients
who had been hospitalized for acute stroke and
history of hypertension between 1st January and 31st
December 2001 were deﬁned as cases (n ¼ 180).
According to exclusion criteria, 68 (38%) cases were
excluded. In total 112 (62%) cases were ultimately
selected from the registers. The diagnosis of stroke
was conﬁrmed by a physician and a head CT scan
was performed. Stroke was deﬁned as ‘a sudden loss
of brain function resulting from disruption of the
blood supply to a part of the brain’ [21].
Controls were deﬁned as having hypertension only,
without history of stroke prior to interview. Controls
may have developed stroke later on after the study
period. The occurrence of potential later development
of stroke in controls after the interview was studied
for the period of the study by telephone follow-up
interview and clinic visits. During the period of the
study no one of the controls developed stroke. These
patients with a diagnosis of hypertension received
health care follow-up because of anti-hypertensive
medication in eight governmental primary health care
clinics. Controls were selected from the same primary
health care clinics where cases used to receive follow-
up appointments for hypertension on primary health
care level before hospital admission due to the
development of stroke.
Inclusion/exclusion criteria
Both, cases and controls had received anti-hyperten-
sive pharmaceutical treatment for at least one year
before enrollment into the study. A physician made a
diagnosis of stroke and/or hypertension.Hypertension
was deﬁned when the threshold levels of 140 mm Hg
systolic and 90 mm Hg diastolic were reached at three
diﬀerent independent measurements within one week,
repeated twice over a 2 months period prior to the
diagnosis of hypertension. Further grading into mild,
moderate, severe hypertension was not made. A com-
puted tomography head scan had been carried out in
patients with stroke. Both groups were selected only, if
a history of other physical diseases (diabetes, myo-
cardial infarction, atrial ﬁbrillation, pulmonary oede-
ma, asthma) was excluded. Sixty-eight (38%) out of
180 selected cases were excluded from the study: 19
(28%) died after ﬁrst stroke; eighteen (26%) had a
second stroke; seven subjects (10%) were over 69-
years-old; 10 (15%) participated in the pilot study;
seven (10%) patients had no computer tomography
head scan; four (6%) refused to participate in the
study; three (4%) patients started their therapeutic
regimen less than one year. Patients participating in the
pilot study and test–retest study were excluded to
reduce response bias.
Study design
A one to two matched case-control study was carried
out. The case group consists of 112 subjects with
stroke and history of hypertension only, and the
control group consists of 224 subjects with hyper-
tension only. Cases and controls were matched by
age, sex, starting point of therapeutic regimen for
both pharmacological and non-pharmacological
treatment, time of hypertension, enrollment location
of hospital related health care clinics and calendar
time. For each case two identical controls were
recruited to detect small diﬀerences between the two
groups [24] and to compensate potential loss of
controls. To test feasibility, validity and reliability of
the instrument a small-scale study was carried out by
using a small sample consisting of 10 cases of stroke
with history of hypertension (ﬁve males and ﬁve
females), and 20 patients with hypertension only as a
control group. Minor adjustment of the question-
naire was done. Probands of the pilot study were
excluded from study population.
Questionnaire
The questionnaire has been developed from two
sources. The ﬁrst part, which deals with personnel,
(age, sex, address, marital status, number of chil-
dren), medical, and socio-economic status, was
developed by ourselves, and the second part, which
deals with therapeutic regimen (anti-hypertensive
medications, dietary restriction of sodium and fat,
weight reduction, exercise program, follow-up health
care) has been adopted from a medical-surgical book
[21]. Compliance with anti-hypertensive medication
was measured with three single categorical (‘yes’ vs.
‘no’) items [(1) ‘medication taking as prescribed’; (2)
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